Literature DB >> 8044792

In vitro mutational spectrum of aflatoxin B1 in the human hypoxanthine guanine phosphoribosyltransferase gene.

N F Cariello1, L Cui, T R Skopek.   

Abstract

The in vitro mutational spectrum of aflatoxin B1 (AFB1) in exon 3 of the human hypoxanthine guanine phosphoribosyltransferase gene in B-lymphoblasts was examined by a combination of polymerase chain reaction and denaturing gradient gel electrophoresis. The cell line used in this study contained an expression vector that produced high levels of human cytochrome P450 CYP1A1. CYP1A1 metabolizes AFB1 to form an epoxide intermediate which can react with DNA. About 1200 independent mutants were induced at the hypoxanthine guanine phosphoribosyltransferase locus by AFB1 and were selected en masse by addition of 6-thioguanine to the bulk culture. Two independent cultures were treated with AFB1. Polymerase chain reaction was used to amplify exon 3 from the complex mutant population, and denaturing gradient gel electrophoresis was used to separate wild-type DNA sequences from mutant sequences. Mutational hotspots were visible as discrete bands on the denaturing gradient gel. Scanning densitometry was used to determine the fraction of the complex population that was represented in each non-wild-type band. The bands containing the mutations were excised from the denaturing gradient gel and sequenced. In this way, the nature and frequency of mutational hotspots in a population of > 1000 mutants were determined. AFB1 produced one strong mutational hotspot in exon 3. Between 10 and 17% of the AFB1-induced mutants contained a single GC-->TA base substitution at base pair 209. This hotspot occurred in a GGGGGG sequence (the mutated base is underlined). This mutation was observed reproducibly in two independently treated cultures. Several other mutations were observed in only one culture but at a lower frequency. Our results are the first report of the mutational spectrum of AFB1 in a native human gene.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8044792

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  4 in total

1.  Altered DNA mutation spectrum in aflatoxin b1-treated transgenic mice that express the hepatitis B virus x protein.

Authors:  Charles R Madden; Milton J Finegold; Betty L Slagle
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

2.  Human tumor p53 mutations are selected for in mouse embryonic fibroblasts harboring a humanized p53 gene.

Authors:  Zhipei Liu; Manfred Hergenhahn; Heinz H Schmeiser; Gerald N Wogan; Amanda Hong; Monica Hollstein
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-19       Impact factor: 11.205

Review 3.  Impact of DNA lesion repair, replication and formation on the mutational spectra of environmental carcinogens: Aflatoxin B1 as a case study.

Authors:  Bogdan I Fedeles; John M Essigmann
Journal:  DNA Repair (Amst)       Date:  2018-08-25

Review 4.  Human biomonitoring: research goals and needs.

Authors:  W A Suk; G Collman; T Damstra
Journal:  Environ Health Perspect       Date:  1996-05       Impact factor: 9.031

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.